Genprex, Inc.
GNPX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $7 | $15 | $26 | $23 |
| Gross Profit | -$7 | -$15 | -$26 | -$23 |
| % Margin | – | – | – | – |
| R&D Expenses | $10,535 | $17,617 | $11,510 | $8,971 |
| G&A Expenses | $0 | $13,444 | $0 | $0 |
| SG&A Expenses | $10,632 | $13,444 | $12,295 | $11,677 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $21,167 | $31,061 | $23,805 | $20,648 |
| Operating Income | -$21,174 | -$31,076 | -$23,831 | -$20,670 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $63 | $215 | $90 | $5 |
| Pre-Tax Income | -$21,111 | -$30,860 | -$23,741 | -$20,665 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$21,111 | -$30,860 | -$23,741 | -$20,665 |
| % Margin | – | – | – | – |
| EPS | -266.954 | -1,129 | -990 | -877.5 |
| % Growth | 76.4% | -14% | -12.8% | – |
| EPS Diluted | -266.954 | -1,128 | -990 | -877.5 |
| Weighted Avg Shares Out | 80 | 27 | 24 | 24 |
| Weighted Avg Shares Out Dil | 80 | 27 | 24 | 24 |
| Supplemental Information | – | – | – | – |
| Interest Income | $64 | $215 | $90 | $5 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $7 | $15 | $26 | $23 |
| EBITDA | -$21,104 | -$31,061 | -$23,715 | -$20,642 |
| % Margin | – | – | – | – |